| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jul 23, 2025 | Jul 25, 2025 | Intellia Therapeutics, Inc. | CFO | Sell | 42.5 | -7,462 | -6.57% | ✗ | $104.6K |
| Mar 4, 2024 | Mar 5, 2024 | FATE THERAPEUTICS INC | CFO | Sell | 45.0 | -2,447 | -2.35% | ✓ | $19K |
| Jan 29, 2024 | Jan 30, 2024 | FATE THERAPEUTICS INC | CFO | Sell | 50.0 | -1,849 | -1.75% | ✓ | $9.2K |
| Jan 9, 2024 | Jan 10, 2024 | FATE THERAPEUTICS INC | CFO | Sell | 46.3 | -7,028 | -6.23% | ✗ | $30.7K |
| Jan 2, 2024 | Jan 3, 2024 | FATE THERAPEUTICS INC | CFO | Sell | 41.3 | -5,182 | -4.39% | ✓ | $19K |
| Dec 18, 2023 | Dec 19, 2023 | FATE THERAPEUTICS INC | CFO | Sell | 50.0 | -1,585 | -1.33% | ✓ | $5.5K |
| Aug 18, 2023 | Aug 21, 2023 | FATE THERAPEUTICS INC | CFO | Sell | 46.3 | -4,718 | -3.80% | ✗ | $13.2K |
| Jul 5, 2023 | Jul 6, 2023 | FATE THERAPEUTICS INC | CFO | Sell | 41.3 | -5,182 | -4.00% | ✓ | $25K |
| Jan 10, 2023 | Jan 11, 2023 | FATE THERAPEUTICS INC | CFO | Sell | 46.3 | -7,331 | -5.36% | ✗ | $38.4K |
| Aug 18, 2022 | Aug 19, 2022 | FATE THERAPEUTICS INC | CFO | Sell | 42.5 | -5,135 | -3.62% | ✗ | $153.1K |
| Jan 11, 2022 | Jan 13, 2022 | FATE THERAPEUTICS INC | CFO | Sell | 42.5 | -1,770 | -1.60% | ✗ | $85.8K |
| Dec 20, 2021 | Dec 21, 2021 | FATE THERAPEUTICS INC | CFO | Sell | 22.5 | -15,977 | -12.64% | ✓ | $958.6K |
| Sep 28, 2021 | Sep 30, 2021 | FATE THERAPEUTICS INC | CFO | Sell | 5.0 | -19,460 | -27.08% | ✓ | $1.2M |
| Aug 19, 2021 | Aug 20, 2021 | FATE THERAPEUTICS INC | CFO | Sell | 40.0 | -3,474 | -5.99% | ✗ | $306.6K |